Snowball logo
logo
SCP

Scope Fluidics SA

SCP WAR
136.60-0.20  (0.15%)
Estimate
EPS
-16.97
Beta
0.003
Growth
Revenue, YoY
17.39%
Net income, YoY
-22.49%
FCF, YoY
-256.36%
Forecast
P/E (FWD)
1.1
EPS (FWD)
126.4
About the company
Ticker
SCP
ISIN
PLSCPFL00018
Country
Poland
Sector (GICS)
Healthcare
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.

Frequently asked questions

What sector does Scope Fluidics SA (SCP) operate in?

Scope Fluidics SA belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Scope Fluidics SA (SCP) current stock price?

As of the latest data, Scope Fluidics SA stock price is PLN 136.60, with a previous close of PLN 136.80. Scope Fluidics SA lost -PLN 0.20 in the last trading session, representing a -0.15% loss.

What is Scope Fluidics SA (SCP) current market capitalization?

Scope Fluidics SA market cap is approximately 432.79 million.

What is Scope Fluidics SA (SCP) Earnings Per Share (EPS)?

The trailing EPS is -PLN 16.97, and the forward EPS is PLN 126.40.

What is Scope Fluidics SA (SCP) EBITDA?

Scope Fluidics SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -13.98 million.

Does Scope Fluidics SA (SCP) pay dividends?

No. Scope Fluidics SA does not pay a dividend.

What is Scope Fluidics SA (SCP) beta (volatility) score?

Scope Fluidics SA has a beta of 0.003, indicating lower volatility than the overall market.